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Familial amyloid polyneuropathy (FAP) is a neurodegenerative
disorder associated with extracellular deposition of mutant
transthyretin (TTR) amyloid fibrils, particularly in the peripheral
nervous system. We have hypothesized that binding of TTR
fibrils to the receptor for advanced glycation end products
(RAGE) on critical cellular targets is associated with a destruc-
tive stress response underlying peripheral nerve dysfunction.
Analysis of nerve biopsy samples from patients with FAP (n 
16) at different stages of disease (0–3), compared with age-
matched controls (n  4), by semiquantitative immunohistology
and in situ hybridization showed increased levels of RAGE,
beginning at the earliest stages of the disease (FAP 0; p  0.02)
and especially localized in axons. Upregulation of proinflamma-
tory cytokines (tumor necrosis factor- and interleukin-1) (ap-
proximately threefold; p  0.02) and the inducible form of nitric
oxide synthase (iNOS) (2.5-fold; p  0.04) was also observed
in a distribution overlapping RAGE expression. Tyrosine nitra-
tion and increased activated caspase-3 in axons from FAP
patients ( p  0.03) were apparent. Although these data sug-
gest the presence of ongoing neuronal stress, there was no
upregulation of neurotrophins (nerve growth factor and
neurotrophin-3) in FAP nerves. Studies on cultured neuronal-
like, Schwann, and endothelial cells incubated with TTR fibrils
displayed RAGE-dependent expression of cytokines and iNOS
at early times (6 and 12 hr, respectively), followed by later (24 hr)
activation of caspase-3 and DNA fragmentation. We propose
that the interaction of TTR fibrils with RAGE may contribute to
cellular stress and toxicity in FAP. Furthermore, there is an
apparent lack of responsiveness of Schwann cells in FAP nerve
to provide neurotrophic factors.
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Familial amyloid polyneuropathy (FAP) is a neurodegenerative
disorder characterized by the extracellular deposition of amyloid
fibrils composed of mutant forms of transthyretin (TTR) in
several tissues, particularly the peripheral nervous system (Coim-
bra and Andrade, 1971a,b). Among the point mutations in TTR
promoting amyloidogenesis (Saraiva, 2001), the most common is
a substitution of Val for Met at position 30 (V30M) (Saraiva et al.,
1983). TTR amyloid deposits are distributed diffusely in the
peripheral nervous system, involving nerve trunks, plexuses, and
sensory and autonomic ganglia (Coimbra and Andrade, 1971b).
Amyloid deposits in peripheral nerves occur especially in the
endoneurium, where they appear close to Schwann cells (SCs)
and collagen fibrils (Coimbra and Andrade, 1971a). In severely
affected nerves, endoneurial contents are replaced by amyloid,
and few nerve fibers retain viability. By contrast, the CNS in FAP
is relatively spared, except for the ependymal lining and lepto-
meninges. Outside the nervous system, extensive amyloid depos-
its have been observed throughout connective tissue in a perivas-
cular distribution.
The accumulation of extracellular, crossed -sheet fibrils is a
hallmark of amyloidoses. Pathologically, fibrillar accumulation
appears to be closely linked to dysfunction of the surrounding
cells and vasculature. This view of FAP pathogenesis would
suggest that nerve fiber degeneration results from multifocal
compression by amyloid deposits (Said et al., 1984). However,
unmyelinated fibers (UFs) that are primarily affected in FAP are
more resistant to compression than myelinated fibers (MFs).
Similarly, despite the presence of vascular amyloid, evidence of
compromised blood flow sufficient to adversely affect organ func-
tion has not been demonstrated in FAP (Fujimura et al., 1991).
Local cellular activation, ultimately resulting in cell dysfunc-
tion and death, may contribute to the pathogenesis of amyloid-
related disorders. In Alzheimer’s disease (AD), the close associ-
ation between expression of inflammatory mediators (cytokines,
chemokines, complement proteins, acute phase reactants), acti-
vated astrocytes and microglia, and neuritic plaques has suggested
a prominent role for immune/inflammatory pathways in the neu-
rodegenerative process (Mrak et al., 1995; Smith et al., 1997;
Veerhuis et al., 1999). Among the candidate mechanisms through
which pathogenic forms of amyloidogenic molecules might per-
turb cellular properties is engagement of cellular receptors. The
receptor for advanced glycation end products (RAGE) displays
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increased expression in FAP tissues and has been shown to bind
fibrillar TTR triggering nuclear factor (NF)-B expression
(Sousa et al., 2000). The possible involvement of RAGE in the
biology of amyloidoses was strengthened by the recent demon-
stration that RAGE bound amyloid A, and that blockade of
RAGE suppressed splenic expression of proinflammatory cyto-
kines, NF-B activation, and accumulation of amyloid in a model
of systemic amyloidosis (Yan et al., 2000). RAGE is a member of
the immunoglobulin superfamily with a broad repertoire of li-
gands in addition to amyloid-associated macromolecules, includ-
ing products of nonenzymatic glycoxidation (advanced glycation
end products), proinflammatory mediators (S100/calgranulins),
and amphoterin (Hori et al., 1995; Yan et al., 1996, 1999, 2000;
Hofmann et al., 1999). In each case, the receptor recruits signal
transduction mechanisms, often resulting in a sustained and
pathogenic inflammatory response (Yan et al., 1996; Schmidt et
al., 1999; Hofmann et al., 2001).
In the present work we initiated a systematic evaluation of the
relationship between RAGE and FAP, on the basis of the hy-
pothesis that expression of the receptor in FAP tissue at early
times might contribute to the pathogenesis of evolving cellular
dysfunction.
MATERIALS AND METHODS
FAP patients. Sural nerve biopsy specimens from FAP patients (n  16)
and normal controls (n  4; near-relatives of FAP patients who ulti-
mately turned out not to have mutations in TTR) were available in the
Hospital Geral de Santo Antonio (Porto, Portugal), because this material
was obtained as part of the clinical diagnosis and evaluation of polyneu-
ropathy in this region of Portugal, before the current use of less invasive
methods. Initial characterization of clinical material included morpho-
metric studies of nerve fiber density and abundance of amyloid deposits.
Patients were scanned for mutations in TTR by immunoblotting (Saraiva
et al., 1985). The general characterization of the patients under study is
shown in Table 1.
Morphometric studies were performed on sural nerve biopsy tissue
fixed in glutaraldehyde (2.5%) in 0.1 M cacodylate buffer, pH 7.4, post-
fixed in osmium tetroxide, and embedded in Epon. Quantitation of
myelinated fibers in semithin sections was performed in an area of at
least 0.1 mm 2 at a magnification of 1000. Myelinated fibers were
counted, their diameters were measured, and the density was calculated.
Unmyelinated fibers were counted from thin sections in an area of at
least 0.005 mm 2, and their densities were calculated. A scoring system of
patient material was based on morphometry of MFs and UFs: FAP 0
(n  5), no reduction in the number of fibers (MFs 10,000 fibers/mm 2;
UFs 50,000 fibers/mm 2); FAP 1 (n  4), discrete reduction (MFs
varied between 7000 and 2000 fibers/mm 2; UFs varied between 4000 and
40,000 fibers/mm 2); FAP 2 (n  4), evident reduction (MFs 1000
fibers/mm 2; UFs  10,000 fibers/mm 2); and FAP 3 (n  3), severe
reduction (MFs  1000 fibers/mm 2; UFs absent). Standard values for
control nerves ranged from 7000 to 11,000 fibers/mm 2 for MFs and from
30,000 to 80,000 fibers/mm 2 for UFs (see Table 1).
Amyloid deposition was assessed by Congo red staining and in most
cases was inversely proportional to nerve fiber density (Coimbra and
Andrade, 1971b). In FAP 0 patients, amyloid was absent (by Congo red
staining), but immunohistochemical reaction of TTR was detected. A
semiquantitative index of amyloid deposition in endoneurium and
epineurium included the following: 0, no amyloid; 1, scarce amyloid
deposition; 2, several amyloid deposits; and 3, abundant amyloid. All
histologic measurements were made independently by two pathologists
unaware of the patient’s clinical diagnosis. The presence of Congo
red-positive areas was closely correlated with immunoreactivity with
TTR.
Immunohistochemistry. For immunohistochemical analysis, paraffin
sections were deparaffinated, dehydrated in a modified alcohol series,
and incubated in blocking buffer [1% bovine serum albumin (BSA) and
4% horse serum] for 30 min at 37°C in a moist chamber. Incubation with
primary antibody, at the appropriate dilution in blocking buffer, was
performed overnight at 4°C. Primary antibodies were rabbit polyclonal
anti-TTR IgG (Dako, Glostrup, Denmark; 1:300), murine monoclonal
anti-human RAGE (1:25), polyclonal rabbit anti-RAGE IgG (Yan et al.,
2000) (1:300), goat anti-human interleukin (IL)-1 IgG and goat anti-
human tumor necrosis factor (TNF)- IgG (Santa Cruz Biotechnology,
Santa Cruz, CA; 1:25), rabbit anti- inducible form of nitric oxide synthase
(iNOS) IgG (Chemicon, Temecula, CA; 1:2500), rabbit anti-endothelial
NOS (eNOS) IgG (Chemicon; 1:100), rabbit anti-neuronal NOS (nNOS)
IgG (Chemicon; 1:1000), rabbit anti-3-nitrotyrosine IgG (Chemicon;
1:1000), rabbit anti-activated caspase-3 IgG (PharMingen, San Diego,
CA; 1:25), monoclonal anti-human CD68 IgG1k (Dako; 1:10), monoclo-
nal anti-human CD11b, Mac1 IgG1 (Chemicon; 1:10), monoclonal anti-
myelin basic protein IgG1 (Chemicon; 1:300), rabbit anti-factor VIII IgG
(Sigma, St. Louis, MO; 1:200), monoclonal anti-smooth muscle -actin
IgG2a (Sigma; 1:100), rabbit anti-neurofilament 200 IgG (Sigma; 1:200),
rabbit anti-brain-derived neurotrophic factor (BDNF) IgG (Chemicon;
1:1000), sheep anti-nerve growth factor- (NGF) (Chemicon; 1:500),
and rabbit anti-neurotrophin 3 IgG (NT3) (Chemicon; 1:1000). Antigen
visualization was performed with either biotin–extravidin–alkaline
phosphatase or biotin–extravidin–peroxidase kits (Sigma), using Fast
Red (Sigma) or 3-amino-9-ethyl carbazole (Sigma), respectively, as sub-
strates. On parallel control sections, primary antibody was replaced by
blocking buffer. Double staining was accomplished by decolorizing the
first stain with 95% ethanol and blocking peroxidase activity with hydro-
gen peroxide (3%)/methanol for 15 min. Subsequent immunohistochem-
istry was performed with either affinity-purified alkaline phosphatase- or
peroxidase-conjugated secondary antibody (Sigma). Semiquantitative
analysis of immunohistochemical images was performed with the Uni-
versal Imaging system (NIH). The results shown represent percentage
(SD) of the image area occupied by a particular immunoreactivity.
In situ hybridization. Digoxigenin-labeled probes were transcribed from
the plasmid B379–2A (Brett et al., 1993) containing a 1406 bp fragment
of bovine RAGE and PCRII containing a 470 bp fragment of mouse
IL-1 (a kind gift of Dr Shi Fang Yan, Columbia University, New York),
using the DIG RNA labeling kit (Roche, Indianapolis, IN). Antisense
probe for RAGE was transcribed from the T3 promoter with the plasmid
linearized with XhoI, and control sense probe was transcribed from the
T7 promoter with the plasmid linearized with XbaI. Antisense probe for
IL-1 was transcribed from the T7 promoter with the plasmid linearized
with SpeI, and a control sense probe was transcribed from the SP6
promoter with the plasmid linearized with XhoI. The digoxigenin-
labeled RNA probes were hybridized to cellular mRNA by standard
procedures and detected with anti-digoxigenin alkaline phosphatase-
conjugated antibody. Antibody was visualized with X-phosphate and
nitroblue tetrazolium salt.
Proteins. Human soluble RAGE (sRAGE) was expressed using the
baculovirus system and purified to homogeneity (Yan et al., 1996).
Recombinant TTR was purified from Escherichia coli BL21 transformed
with plasmids carrying wild-type TTR cDNA as described (Almeida et
al., 1997). TTR fibrils were generated from soluble wild-type TTR (2
mg/ml) by incubation with 0.05 M sodium acetate, pH 3.6, for 48 hr at
room temperature (Bonifacio et al., 1996). Formation of amyloid fibrils
was tested by thioflavin T fluorescence. The lipopolysaccharide (LPS)
content of protein preparations was tested using the Limulus amebocyte
assay (Sigma). At a protein concentration of 2 mg/ml, sRAGE had
no detectable LPS. Similarly, TTR at a concentration of 1 mg/ml was
free of LPS.
Cell lines and cell culture. RN22 (rat Schwann cell line), PC12 (rat
adrenal cell line with a neuronal-like phenotype), and BAE-1 (bovine
aortic endothelium cell line) were from the European Collection of Cell
Cultures. Wild-type mouse embryonic fibroblasts (MEF1s) were kindly
provided by Dr. Miguel Seabra (Imperial College, London). All cell lines
were propagated in 10 cm dishes in monolayers and maintained at 37°C
in a humidified atmosphere of 95% and 5% CO2. Cells were grown in
DMEM (Life Technologies, Gaithersburg, MD) supplemented with 10%
fetal bovine serum (FBS) (Life Technologies) and 100 U/ml penicillin
(Life Technologies) (complete media). Primary cultures from dorsal root
ganglion (DRG) were prepared from 250 DRGs from neonatal to
3-week-old mice. DRGs were suspended in DMEM containing 10%
collagenase/dispase stock solution (Sigma) and incubated at 37°C for 1
hr. After dissociation of the tissue, the suspension was centrifuged at
1000 rpm for 10 min, and the resulting pellet was washed with DMEM
three times to remove excess collagenase. For primary SCs, cells were
resuspended in 10 ml per 20 DRGs in DMEM supplemented with 0.1%
BSA, 20% FBS, 30 mM glucose, and 2 mM glutamine and plated in 10 cm
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dishes (10 ml per dish) coated with laminin (Sigma) and incubated for 2.5
hr at 37°C. During this period, nearly all non-neuronal cells attach,
leaving neurons in the culture supernatant. Cell culture media was
aspirated and replaced by fresh media. SCs were grown to a confluent
monolayer over 7 d. To obtain neuron DRG, cells were plated in
Matrigel (Sigma) in neuronal growth media: DMEM supplemented with
100 ng/ml nerve growth factor (Life Technologies), 5% FBS, and 1% B27
supplement (Life Technologies). The purity of primary cultures used for
experiments was 85% neurons and 80% SCs, based on staining with
antibody to neurofilament 200 and myelin basic protein in neuronal and
Schwann cell cultures, respectively.
For RT-PCR and caspase-3 assays, cultured cells were grown in com-
plete media in six-well dishes. For cell death detection, cells were grown
in 96-well plates. When 80% confluence was reached, cells were washed
with HBSS and incubated with assay buffer (DMEM containing 1%
dialyzed FBS) with the indicated amount of either soluble or fibrillar
TTR for the time periods shown for each experiment. For studies using
specific antibodies, nonimmune (NI) IgG or sRAGE, cells were prein-
cubated for 3 hr with the indicated amount of antibody, NI IgG, or
protein (10 g/ml, unless stated otherwise).
RNA extraction and RT-PCR. Total RNA extraction was performed
using Trizol reagent (Life Technologies) according to the manufacturer’s
instructions. The concentration of total RNA was determined spectro-
photometrically in RNase-free water. Reverse transcription was per-
formed using 10 g total RNA and Superscript II (Life Technologies),
primed by oligo-dT following the manufacturer’s instructions. PCR (94°C,
3 min, 1 cycle; 94°C, 20 sec, 56°C, 45 sec, 72°C, 1 min, 30 cycles; 72°C, 6 min,
1 cycle) was performed using 1⁄10 of the obtained cDNA. The following
primers were used: for IL-1, sense (5-ATGGCAACTGTTCCT-
GAACTCAACT-3) and antisense (5-CAGGACAGG TATAGATTCT-
TTCCTTT-3); for mouse and rat TNF-, sense (5-TTCTGT CTACT-
GAACTTCGGGGTGATCGGTCC-3) and antisense (5-GTATGAG-
A TAGCAAATCGGCTGACGGTGTGGG-3); for bovine TNF-, sense
(5-TTCTGTCTACTGAACTTCGGGGTGATTGGTCC-3) and anti-
sense (5-GTATGAAATGGCAAACCGGCTGACGGTGTGGG-3); for
mouse and rat iNOS, sense (5-GGAACCTACCAGCTCACTCTG-3)
and antisense (5-CCACTTC AGCCCGAGCTCCTG-3); for bovine
RAGE, sense (5-AGCGGCTGGAATGGAAA CTGAACA-3) and an-
tisense (5-GAAGGGGCAAGGGCACA CCATC-3); for mouse and rat
RAGE, sense (5-ATGGCAGCAGCGTGTCGGAGC-3) and antisense
(5-GGGACCCTTAGCTGGCACTTAGAT-3); for BDNF, sense (5-
CGGCCCAACG AAGAAAACC-3) and antisense (5-TAAGGGCCCG-
AACATACGATTGG-3); for NGF, sense (5-GGCCCATGGTACAAT-
CCCTTTCA-3) and antisense (5-TCA GCCTCTTCTTGTAGCCT-
TCCT-3); and for NT3, sense (5-AGCCGATTGCA ACAGACAC-3)
and antisense (5-CCAGCGCCAGCCTACGAGT-3). To normalize and
control differences in total RNA concentration among samples, mRNA
levels for -actin were determined by RT-PCR using the following primers
for mouse and rat -actin: sense (5-GTGGGCCGCTCTAGGCACCAA-
3) and antisense (5-CTCTTTGATGTC ACGCACGATTTC-3); and for
bovine -actin, sense (5-CTATCCCTGT ACGCCTCTGGC-3) and an-
tisense (5-GGCGTAGAGGTC TTTGCGGATG-3). All PCR products
were visualized in 1% agarose gels by ethidium bromide staining.
Caspase-3 assays. Activation of caspase-3 was measured using the
CaspACE fluorometric 96-well-plate assay system (Promega, Madison,
WI) following the manufacturer’s instructions. Briefly, 80% confluent
cells were exposed for 24 hr to 1 M TTR (either soluble or fibrils) in the
presence or absence of RAGE or NI IgG. Subsequently each well was
trypsinized, and the cell pellet was lysed in 100 l hypotonic lysis buffer
(Promega) by four cycles of freeze/thawing. Forty microliters of each cell
lysate were used in duplicates for determination of caspase-3 activation.
The remaining cell lysate was used to measure total cellular protein
concentration with the Bio-Rad protein assay kit (Bio-Rad, Hercules,
CA), using BSA as standard. Values shown are the mean of duplicates of
three independent experiments.
Cell death detection. Cell death detection was performed using the cell
death detection ELISAplus kit (Roche) following the manufacturer’s
instructions. Briefly, after incubation with 2 M TTR (either soluble or
fibrils) for 24 hr, in the presence or absence of RAGE or NI IgG, 60 l
lysis buffer (Roche) was added to each well and 40 l was used in the
assay. Results presented are the mean of triplicate wells of two indepen-
dent experiments.
RESULTS
Increased expression of RAGE in peripheral nerve
from early FAP patients
We reported previously that FAP patients had increased expres-
sion of RAGE in affected peripheral nerves (Sousa et al., 2000).
These results led us to perform a more detailed analysis of
RAGE expression in FAP by analyzing sural nerve biopsies from
16 patients spanning different stages of FAP (Table 1). Patients
were scored using a morphometric scale based on nerve fiber
density (0–3, the latter representing the greatest loss of nerve
fibers; see Materials and Methods). FAP 0 patients possess the
V30M mutant form of TTR, normal nerve fiber density, and
deposition of TTR in nerve tissue, but amyloid is not evident (i.e.,
immunoreactive deposits are negative by Congo red staining). It
should be noted that at all other stages of FAP (1–3), immuno-
reactive TTR and Congo red-positive deposits were highly cor-
related. RAGE expression was enhanced in nerves of FAP 0
patients (Fig. 1A). Although RAGE was present in several cell
types, our initial impression was that the staining pattern was
most consistent with increased expression of the receptor in
axons (see below). Analysis of images of five biopsies of FAP 0
patients, compared with normal age-matched controls (n  4),
demonstrated an approximately threefold increase in area occu-
pied by immunoreactive RAGE in the patients (Fig. 1B) ( p 
0.02). As the course of FAP evolved, there was a tendency for
RAGE expression to increase. Semiquantitative analysis showed
a statistically significant difference between all stages of FAP
(0–3) and controls ( p  0.003). Although there was no statisti-
cally significant difference between FAP 1 and FAP 2, there was
a significant difference between FAP 0 and FAP 3 (Fig. 1B) ( p 
0.01).
Neuronal expression of RAGE in FAP
Because of the likely presence of RAGE in several cell types in
nerve tissue from patients with FAP, a more detailed analysis to
match cells expressing RAGE with those displaying markers for
neurons, vascular endothelium, and Schwann cells was under-
taken. Neurons showed increased RAGE staining based on co-
localization with the neuron-specific marker neurofilament 200
(Fig. 1C, top panels). Vascular endothelium stained positively for
RAGE and the endothelial marker Factor VIII (Fig. 1C, middle
panels). It was apparent that RAGE was also present in vascular
smooth muscle cells. In some cases, we found that RAGE immu-
noreactivity coincided with Schwann cells (Fig. 1C, bottom pan-
els). Based on our survey of cells bearing RAGE antigen in FAP
nerves, axons were the most abundant cellular structure display-
ing positive staining. Consistent with this impression, in situ
hybridization using an antisense RAGE probe showed transcripts
of the receptor to be predominately localized to axons of FAP
nerves (Fig. 1D, top panel). Control hybridizations with either a
sense RAGE probe and FAP tissue (Fig. 1D, middle panel) or an
antisense RAGE probe in nerve from a control individual (Fig.
1D, bottom panel) resulted in only background staining.
Expression of inflammatory cytokines in FAP nerve
Previous studies demonstrated RAGE-dependent activation of
NF-B by TTR fibrils in vitro and nuclear staining for NF-Bp50
in FAP tissues (Sousa et al., 2000). Because nuclear translocation
of NF-B might underlie increased expression of proinflamma-
tory cytokines, we analyzed the presence of two key mediators,
IL-1 and TNF-, in affected nerves from FAP patients in
relation to deposition of TTR. Semiquantitative analysis of im-
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munohistochemical images for immunoreactive TNF- and
IL-1 in FAP nerve biopsies, compared with age-matched control
individuals, demonstrated expression of these cytokines that co-
incided with the pattern observed for RAGE; namely, they were
especially localized to the endoneurial axons (Fig. 2A). Although
normal nerve showed virtually no detectable antigen, FAP 0
individuals (i.e., before amyloid was present) already displayed
increased TNF- and IL-1 antigens (Fig. 2A,B). Increased
levels of these cytokines were also evident in FAP 1–3 individu-
als, in which case the pattern of TNF- and IL-1 appeared
juxtaposed to deposits of TTR. In each case, the level of
cytokine appeared to increase by approximately threefold,
compared with controls, and was statistically significant (Fig.
2 B). In situ hybridization was performed to determine the
actual site of IL-1 mRNA synthesis. Antisense probe hybrid-
ized with FAP 1 tissue demonstrated a clear signal, consistent
with axons as the principal site of IL-1 transcripts (Fig. 2C).
In contrast, study of FAP 1 tissue with the sense IL-1 probe
and control tissue with the antisense IL-1 probe displayed
only background staining.
Local expression of TNF- and IL-1 in peripheral nerve
suggested the possible recruitment of leukocytes, lymphocytes,
and mononuclear phagocytes to FAP lesions. However, our stud-
ies using antibodies reactive with markers on polymorphonuclear
leukocytes (CD68), lymphocytes (CD11b, Mac1), and mononu-
clear phagocytes (F4/80) did not confirm the presence of these
subpopulations of white cells. An important consideration in the
interpretation of these data is that our samples were preserved in
glutaraldehyde, paraffin-embedded, and stored for prolonged
times. Thus, it is possible that loss of immunoreactivity could
account for some of these results. However, in view of the number
of antibodies tested and the absence of cellular infiltrates in FAP
nerve tissue, at the level of general histologic analysis, it seems
likely that there is a relative paucity of white cells in these lesions.
Oxidant stress in FAP
Oxidant stress attributable to generation of reactive oxygen and
nitrogen species is likely to have an important role in neurode-
generative and neuroinflammatory disorders (Calabrese et al.,
2000). High levels of NO, produced by iNOS, are known to exert
multiple toxic effects on cells (Combs et al., 2001). In view of the
well known link between cytokines and expression of iNOS, we
probed FAP nerves for iNOS antigen. Increased levels of iNOS
were observed in FAP nerves, especially in axons, in a distribu-
tion overlapping that for both RAGE and proinflammatory cy-
tokines in FAP 0 and FAP 3 (Fig. 3A). On the basis of our
semiquantitative immunohistologic evaluation of the different
stages of FAP, enhanced expression of iNOS was evident in FAP
0 patients (approximately twofold) compared with controls ( p 
0.04) (Fig. 3B). Furthermore, this increase was also seen in later
stages of the disease (FAP 1–3), where it approached 2.5-fold
( p  0.02). In contrast to these data regarding iNOS expression,
no increase in immunoreactive eNOS or nNOS was observed
when the same sections were analyzed (data not shown).
The reaction of NO with superoxide produces the peroxynitrite
anion (Radi et al., 2001). Peroxynitrite is a powerful oxidant that
can nitrate aromatic amino acid residues such as tyrosine to form
3-nitrotyrosine (3-NT). Thus, 3-NT is a useful marker of per-
oxynitrite production. Immunostaining of FAP nerves with anti-
body to 3-NT demonstrated immunoreactive material in FAP 0
Table 1. Clinical pathologic analysis of FAP patients
FAP stage Age (years)
Amyloid deposition Fiber density (fibers/mm2)
Endoneurium Epineurium MF UF
FAP 0
1 25 0 0 8,700 nd
2 17 0 0 7,700 41,500
3 33 0 0 10,300 54,800
4 25 0 0 10,800 57,900
5 21 0 0 10,300 80,000
6 25 0 0 7,700 nd
FAP 1
7 25 2 0 4,360 41,000
8 27 2 0 2,370 nd
9 27 2 1 2,460 4,080
10 nd 1 1 7,270 32,750
FAP 2
11 41 2 1 1,620 1,000
12 nd 1 0 1,840 9,600
13 41 2 0 1,140 1,000
14 58 2 1 1,300 1,000
FAP 3
15 43 3 0 720 0
16 41 3 1 0 0
17 34 3 1 910 0
Controls
18–21 36–53 0 0 7,000–11,000a 30,000–80,000a
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and FAP 3 tissue in an axonal distribution (Fig. 3C). The latter
also showed intense staining of deposited TTR with the antibody
to 3-NT, suggesting that the deposited TTR was subject to nitra-
tion (Fig 3C, right panel).
Activation of an apoptotic pathway by TTR
fibril–RAGE interaction
Apoptosis is a common mechanism of cell death in neurodegen-
erative disorders (Hengartner, 2000). In the case of FAP, local
expression of cytokines and iNOS in neurons suggested even
more strongly that programmed cell death might be triggered.
Apoptosis involves the activation of a proteolytic cascade where
caspases have a key regulatory role (Hengartner, 2000).
Caspase-3 is especially significant in this regard, because it is
activated late in apoptosis. Immunostaining of FAP nerve biop-
sies was performed with an antibody specific for activated
caspase-3. A representative micrograph of control and FAP 3
tissue demonstrates undetectable staining in the normal tissue,
whereas FAP shows areas of intense staining corresponding to
axons (Fig. 4A). This pattern overlapped that for expression of
iNOS, inflammatory cytokines, and RAGE in FAP 3 biopsies.
Comparison of results in FAP patients at each of the four stages
indicated a tendency for increased activation of caspase-3, start-
ing in FAP 0 patients but being more pronounced (fourfold; p 
0.003) in FAP 2 and 3 (Fig. 4B) (approximately fourfold; p 
0.003). To determine whether DNA fragmentation had occurred,
TUNEL staining was attempted on the biopsy samples. However,
the results could not be interpreted because of artifacts probably
related to sample preparation and storage (similar results were
obtained with the Apoptag kit as well).
Binding of TTR fibrils to RAGE induces cell stress,
ultimately resulting in cytotoxicity
In vitro studies were performed to address whether the interaction
of TTR fibrils with RAGE-bearing cells might recapitulate cell
stress observed in FAP nerve biopsies. Although proinflamma-
tory cytokines and iNOS appeared most concentrated in periph-
eral nerve axons, the presence of amyloid contiguous to Schwann
cells and associated with the vasculature suggests the potential for
interactions with these cellular elements as well. For these exper-
iments, cell culture models were used: PC-12 cells for neuronal-
like cells, BAE-1 for vascular endothelium, and RN-22 for
Schwann cells, as well as primary cultures of dorsal root ganglion
neurons and Schwann cells. RT-PCR analysis demonstrated ex-
Figure 1. RAGE expression in FAP nerves. A,
Representative TTR (lef t) and RAGE (right)
immunohistochemistry of nerves from normal
individuals (top panel ), FAP 0 patients (middle
panel ), and FAP 3 patients (bottom panel ); 40
magnification. B, Quantitation of immunohisto-
chemical images corresponding to RAGE stain-
ing in control individuals (n  4) and FAP 0–3
(n  16) patients. Data are represented as per-
centage area occupied  SD (*p  0.003, ‡ p 
0.02). C, Colocalization of RAGE with the neu-
ronal marker neurofilament 200 (N200, top pan-
el ), an endothelial cell marker (Factor VIII, mid-
dle panel ), and an SC marker, myelin basic
protein (MBP, bottom panel ); 40 magnifica-
tion. Nerve tissue from a representative FAP 2
patient was used. D, In situ hybridization for
RAGE mRNA in a representative FAP 1 nerve
with an antisense riboprobe (top panel ) and a
control sense riboprobe (middle panel ). The bot-
tom panel shows a nerve from a control hybrid-
ized with the antisense RAGE riboprobe.
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pression of RAGE transcripts in each of these cell types (Fig.
5A). Cultures were incubated with TTR fibrils for 12 hr, and
expression of TNF- and IL-1 transcripts was studied by PCR.
Induction of transcripts for each of these cytokines was observed
in the different cell types by fibrillar, but not soluble, TTR (Fig.
5B). Furthermore, antibody blocking experiments demonstrated
that preincubation of cultures with anti-RAGE IgG prevented
cytokine expression, whereas nonimmune IgG at the same con-
centration was without effect (Fig. 5B). In contrast to these results
with RAGE-bearing cells, we also studied cultured MEF1. These
cells did not display RAGE transcripts (Fig. 5A) and when
exposed to TTR fibrils did not display induction of TNF- or
IL-1 transcripts (Fig. 5B).
In view of enhanced expression of iNOS in FAP biopsies, we
used the same cell culture system to assess the effect of TTR
Figure 2. Expression of proinflammatory cytokines in FAP. A, Repre-
sentative TNF- (lef t) and IL-1 (right) immunohistochemistry of nerves
from normal individuals (top panel ), FAP 0 patients (middle panel ), and
FAP 3 patients (bottom panel ); 40 magnification. B, Quantitation of
immunohistochemical images of TNF- and IL-1 staining in control
individuals (n  4) and FAP (n  16) patients. Data are represented as
percentage area occupied  SD (*p  0.01, ‡ p  0.02). C, In situ
hybridization of IL-1 mRNA in a representative FAP 1 nerve with an
antisense riboprobe (lef t panel ) and a control sense riboprobe (middle
panel ). The far right panel shows in situ hybridization with the antisense
IL-1 riboprobe and a control nerve (right panel ).
Figure 3. Oxidative stress in FAP. A, iNOS immunohistochemistry of
representative nerves from a normal individual (lef t panel ), FAP 0 (mid-
dle panel ), and FAP 3 patients (right panel ); 40 magnification. B,
Quantitation of immunohistochemical images of iNOS staining in control
individuals (n  4) and FAP patients (n  16). Data are represented as
percentage area occupied  SD (*p  0.01, ‡ p  0.02). C, 3-NT immu-
nohistochemistry of representative nerves from normal individuals (lef t
panel ), an FAP 0 patient (middle panel ), and an FAP 3 patient (right
panel ); 40 magnification.
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fibril–RAGE interaction on transcripts for iNOS. Using RN-22
cells, mouse Schwann cells, and PC-12 cells, TTR fibrils, but not
soluble TTR, induced transcripts for iNOS (Fig. 5C). Expression
of iNOS mRNA in mouse Schwann cells and PC-12 cells exposed
to TTR fibrils was blocked by anti-RAGE IgG, but not by
nonimmune IgG (Fig. 5C). These data are consistent with the
capacity of RAGE engagement by TTR fibrils to activate signal-
ing cascades in critical target cells for amyloid, resulting in ex-
pression of mediators observed in FAP nerve biopsies.
Binding of TTR fibrils to RAGE induces cell death
Complementary experiments were performed in cell cultures
with PC12 and RN-22 cells to determine whether sustained
RAGE interaction with TTR fibrils (24 hr) might push cells into
an apoptotic pathway. RN22 cells incubated with TTR fibrils (the
latter preparations were composed of short fibrils and aggregates
of TTR, determined on the basis of electron microscopy; data not
shown) displayed increased caspase-3 activity in a dose- and
time-dependent manner (Fig. 6A,B). Only fibrillar TTR was able
to induce caspase-3 activity, whereas soluble TTR was without
effect (Fig. 6C). Blockade of RAGE, using anti-RAGE IgG,
demonstrated dose-dependent suppression of caspase-3 activity
(by 60%), whereas nonimmune IgG at the same concentration
was without effect (Fig. 6C). Furthermore, addition of excess
soluble RAGE, the extracellular portion of the receptor that
binds ligand and prevents its interaction with cell surface RAGE,
similarly prevented caspase-3 activation (Fig. 6C). PC-12 cells
also displayed RAGE-dependent activation of caspase-3 after 24
hr of incubation with fibrillar TTR (Fig. 6D).
These results were consistent with the induction of pro-
grammed cell death in RN-22 and PC-12 cells exposed to RAGE
ligands for 24 hr. To ascertain whether the cell death pathway had
actually been triggered, DNA fragmentation was evaluated. In-
cubation of fibrillar TTR, but not soluble material at the same
concentration, with RN-22 and PC-12 cells caused an increase in
DNA fragmentation in each of the cell types (Fig. 6E,F). In each
case, addition of anti-RAGE IgG blocked DNA fragmentation
caused by fibrillar TTR by 70% (Fig. 6E,F).
Schwann cell expression of neurotrophins in response
to TTR: in vitro and in vivo studies
Neurotrophins, namely BDNF, NGF, and NT-3, have an impor-
tant role in the survival and regeneration of neuronal populations
(Frostick et al., 1998). After nerve injury, both NGF and BDNF
mRNAs, normally present at low levels in the nerve, increase in
SCs (Frostick et al., 1998). In contrast, NT-3 expression is gen-
erally downregulated after nerve injury. In the case of FAP, no
studies addressing trophic support of neurons have been reported.
To assess the effect of TTR fibrils on neurotrophins, RN22 cells
were incubated with TTR for 12 hr, and mRNA for NGF and
NT-3 was monitored by RT-PCR. Fibrillar TTR, but not soluble
TTR, induced transcripts for both NGF and NT-3 (Fig. 7A). In
contrast, BDNF expression remained at low levels despite the
presence of fibrillar TTR (Fig. 7A). However, when we assessed
the expression of these neurotrophins in FAP nerve biopsies by
immunohistochemistry, there were no changes in their expression
in FAP nerves, compared with samples from control subjects (Fig.
7B,C). In fact, the expression of NGF actually decreased in FAP3
patients ( p  0.002), and this decrease seemed most prominent in
Figure 4. Apoptosis in FAP. A, Active caspase-3 immunohistochemical
staining of a representative FAP 3 (right) and control nerve (lef t); 40
magnification. B, Quantitation of immunohistochemical images of active
caspase-3 staining in control individuals (n  4) and FAP patients (n 
16). Data are represented as percentage area occupied  SD (*p  0.003,
‡ p  0.03).
Figure 5. RAGE-dependent activation of proinflammatory cytokines
and iNOS by TTR fibrils. A, RT-PCR analysis of RN22, BAE1, PC12,
primary SC, neuron-DRG, and MEF1 cells with primers for RAGE. B,
RT-PCR analysis of RN22, neuron-DRG, primary SC, PC12, BAE1, and
MEF1 cells with primers for TNF-, IL-1, and -actin. Cells were
exposed for 6 hr to assay buffer (Control ), 0.5 M soluble TTR (sTTR), or
0.5 M TTR fibrils ( fTTR). Where indicated, cells were preincubated
with 10 g/ml of polyclonal anti-RAGE (RAGE) or nonimmune IgG
(NI ), and then exposed to fTTR (0.5 M). C, RT-PCR analysis of RN22,
PC12 cells, and mouse primary SC with primers for iNOS and -actin.
Cells were exposed for 12 hr to assay buffer (Control ), 0.5 M soluble
TTR (sTTR), or 0.5 M TTR fibrils ( fTTR). Where indicated, cells were
preincubated with 10 g/ml of polyclonal anti-RAGE (RAGE) or non-
immune IgG (NI ) and then exposed to fTTR (0.5 M).
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proximity to sites of massive TTR deposition (Fig. 7B). These
data suggest an apparent lack of responsiveness of the SC in vivo
in the setting of FAP to produce neurotrophins in a context of
apparent neuronal stress. In contrast, cultured SCs exposed to
neurotrophins did display increased expression of NGF and NT-3.
DISCUSSION
Although not as common as other forms of amyloidoses, such as
Alzheimer’s disease, FAP is a devastating neurodegenerative
disorder for certain populations, such as those in northeast Por-
tugal. Traditionally, it has been postulated that amyloid physically
displaces normal elements of peripheral nerves, ultimately result-
ing in neuronal loss. Our data indicate that evidence of neuronal
stress in patients with FAP begins at a very early stage; increased
expression of RAGE, proinflammatory cytokines, and iNOS in
peripheral nerve axons was observed before amyloid deposits
were detected based on Congo red staining (FAP 0). This leads to
the following question: what starts off the cascade of cellular
perturbation, especially if the amyloid deposits do not seem to be
the primary cause? Because mutant TTR must be at the root of
the problem, we propose that “pathogenic” forms of TTR derived
from the amyloidogenic variants, but not sufficiently abundant to
appear as Congophilic deposits, are likely to be involved. In view
of previous data demonstrating that normal TTR binds RAGE
only when not complexed with its physiologic ligand retinol bind-
ing protein and that preformed fibrils of TTR (whether derived
from mutant or wild-type transthyretin) similarly interact with
the receptor (Sousa et al., 2000), it is possible that deposition of
TTR in the form of small aggregates free of retinol binding
protein occurs locally before overt amyloid deposition. This sce-
nario would be consistent with the emerging role for pathogenic
forms of amyloid- peptide in cellular perturbation underlying
Alzheimer’s disease (Eisenhauer et al., 2000). Experiments in
transgenic mice expressing mutant forms of amyloid- precursor
protein associated with familial Alzheimer’s disease have shown
the development of electrophysiologic and other changes in cel-
lular function before or even without the presence of parenchy-
mal plaques (Hsiao et al., 1995; Hsia et al., 1999). Consistent with
this concept, toxic effects of soluble, relatively small A assem-
blies have been observed (Roher et al., 1996). However, the
precise nature of the pathogenic A species is far from clear,
ranging from mature fibrils to much smaller assemblies (Hensley
et al., 1994; Snyder et al., 1994; Lorenzo and Yankner, 1996;
Walsh et al., 1999).
Figure 6. A, Dose-dependent induction of caspase-3 activity in RN22
cells exposed for 24 hr to the indicated amounts of TTR fibrils (*p 
0.001, ‡ p  0.004). B, Time-dependent induction of caspase-3 activity in
RN22 cells exposed for the indicated times to 1 M TTR fibrils.
4
C, Activation of caspase-3 in RN22 cells exposed for 24 hr to either 1 M
soluble TTR (sTTR) or 1 M TTR fibrils ( fTTR). Where indicated, cells
were preincubated with polyclonal anti-RAGE (RAGE), nonimmune
IgG (NI ), or 20 molar excess of soluble RAGE (sRAGE). Then these
cultures were exposed to fTTR (1 M) (*p  0.001, ‡ p  0.003). D,
Activation of caspase-3 in PC12 cells exposed for 24 hr to either 1 M
soluble TTR (sTTR) or 1 M TTR fibrils (fTTR). Where indicated, cells
were preincubated with polyclonal anti-RAGE (RAGE), nonimmune
IgG (NI ), or 20 molar excess of soluble RAGE (sRAGE). Then these
cultures were exposed to fTTR (1 M) *p  0.001, ‡ p  0.003). E, DNA
fragmentation in RN22 cells exposed for 24 hr to assay buffer (Control ),
2 M soluble TTR (sTTR), or 2 M TTR fibrils ( fTTR). Some cells were
preincubated with 10 g/ml of polyclonal anti-RAGE (RAGE) or non-
immune IgG (NI ) (*p  0.005, ‡p  0.02). F, DNA fragmentation in PC12
cells exposed for 24 hr to assay buffer (Control ), 2 M soluble TTR
(sTTR), or 2 M TTR fibrils ( fTTR). Where indicated, cells were prein-
cubated with 10 g/ml polyclonal anti-RAGE (RAGE) or nonimmune
IgG (NI ) (*p  0.004, ‡ p  0.01).
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Although further experiments will be required to understand
the nature of the pathogenic form(s) of TTR relevant to the
earliest stages of FAP, our data clearly demonstrate that RAGE
is upregulated in peripheral neurons at early times and that this
is magnified and persists throughout the course of the disease. In
this context, it should be noted that the fibrillar material prepared
in vitro for our cell culture experiments was composed of short
fibrils and amorphous aggregates (by ultrastructural analysis).
This is quite similar to the composition of TTR immunoreactive
deposits from FAP 0 patients based on electron microscopy (M.
Sousa, D. Stern, and M. Saraiva, unpublished observations). In
view of the coinciding expression of RAGE and markers of cell
stress in FAP nerves, it is tempting to speculate that these events
may be related. Support for such an association must await the
development of an appropriate animal model of TTR amyloid
polyneuropathy. However, the results of our cell culture studies
suggest that RAGE-induced cellular perturbation could prove
relevant. Experiments in rat pheochromocytoma PC-12 cells
demonstrated early induction of cytokines and iNOS. On the
basis of previous results demonstrating that TTR fibrils cause
activation of NF-B in a RAGE-dependent manner (Sousa et al.,
2000), it is possible that the latter underlies increased iNOS
expression. Such observations also suggest that early in the dis-
ease, RAGE-induced cell stress might serve a protective role,
because NF-B promotes anti-apoptotic programs, including
transcription of inhibitor of apoptosis protein genes (Chu et al.,
1997). However, longer incubations of TTR fibrils with PC-12
cells pushed them into an apoptotic pathway, as evidenced by
increased capase-3 activity and DNA fragmentation. Thus, the
ultimate consequence of sustained RAGE-TTR fibril interaction
in the context of PC-12 cells is one of cell death. The latter might
result from ligand-induced upregulation of RAGE (Schmidt et
al., 2000) recruiting additional signaling pathways that ultimately
overwhelm protective mechanisms. These observations suggest
the relevance of RAGE–ligand interaction in the progression
from cell stress to apoptosis, which fits the protracted course of
neurodegenerative disorders.
One of the most striking features of our in vivo data concerns
the lack of changes in Schwann cells in FAP biopsies (in terms of
expression of RAGE, cytokines, iNOS, and neurotrophins), al-
though previous studies would suggest that they are intimately
associated with amyloid deposits (Coimbra and Andrade,
1971a,b). In fact, our initial hypothesis was that RAGE-bearing
Schwann cells might provide a source of mediators ultimately
impacting negatively on the function of peripheral neurons. How-
ever, upregulation of RAGE, TNF-, IL-1, and iNOS in FAP
biopsies was particularly evident in neurons, not in Schwann cells.
In contrast, our studies with cultured Schwann cells, both a cell
line and primary cultures derived from dorsal root ganglia, dem-
onstrated expression of RAGE and the capacity to evolve the
same response mechanisms as PC-12 cells, with respect to expres-
sion of mediators after exposure to TTR fibrils. At present, it is
unclear why Schwann cells did not display upregulation of
RAGE, cytokines, or iNOS in FAP nerve biopsies. These results
led us to consider the alternative hypothesis that Schwann cells in
FAP might impact on neuronal properties via an indirect mech-
anism, namely diminished expression of neurotrophic factors.
Consistent with this concept, our studies evaluating the expres-
sion of BDNF, NGF, and NT-3 did not show increased expression
in FAP nerve biopsies, in either SC or other cellular elements.
The consequent lack of trophic factors might be relevant for
neuronal dysfunction and, ultimately, cell death in FAP. The
reason for the apparent lack of SC responsiveness, with respect to
the host response to TTR amyloid in FAP, is not clear and
requires further analysis.
Figure 7. Neurotrophin expression in FAP. A, RT-PCR analysis using
primers for BDNF, NGF, and NT3, of RN22. Cells were exposed for 12
hr to assay buffer (control), 1 M sTTR, or 1 M fTTR. B, NGF
immunohistochemistry of representative nerves from normal individuals
(top panel ), FAP 0 patients (middle panel ), and FAP 3 patients (bottom
panel ); 60 magnification. C, Quantitation of immunohistochemical im-
ages corresponding to NGF, BDNF, and NT-3 staining in control indi-
viduals (n  3) and FAP patients (n  16). Data are represented as
percentage area occupied  SD (*p  0.002).
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Another striking feature of FAP nerve biopsies was the lack of
an immune/inflammatory infiltrate despite the production of
IL-1 and TNF- by axons. Although it might be argued that the
cytokines are not effectively released into the nerve bed (be-
cause staining was largely restricted to axons), it is more likely
that free polypeptides diffused away from the axon and were
not adequately visualized by immunostaining. Furthermore,
we would predict that other mechanisms must be operative to
prevent recruitment of immune/inflammatory effector cells.
This pathologic picture is certainly different from what is
observed in the CNS. Neuritic plaques in Alzheimer’s disease
are well known for their association with activated microglia
and astrocytes, which might contribute to protective or patho-
genic mechanisms (Akiyama et al., 2000). In this context, it is
possible that if a humoral immune response selective for patho-
genic TTR species could be elicited in humans (by analogy
with A immunization studies in mice) (Schenk et al., 1999;
Janus et al., 2000; Morgan et al., 2000), resulting in attraction
of mononuclear phagocytes to sites of amyloid deposition,
these cells might accelerate amyloid clearance. Considering
the apparent absence of mononuclear phagocytes in FAP le-
sions, the results of an influx of such cells for removing amyloid
could be considerable, although the ultimate outcome for neu-
ronal function might be complex (especially if products of
inflammatory cells perturbed neuronal function).
The results of our experiments provide support for a possible
link between RAGE and neuronal dysfunction underlying FAP.
Although future studies will be required to establish whether this
link reflects a cause–effect relationship, our studies have already
provided insights into selective neuronal perturbation in FAP
biopsies occurring before overt amyloid deposition.
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